Use of aromatase inhibitors for treatment of ectopic pregnancy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 1, 2014
Grant Date -
Jan 31, 2008
app pub date -
Oct 4, 2005
filing date -
Oct 4, 2004
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Following a diagnosis of ectopic pregnancy, at least one aromatase inhibitor, is administered to a patient, either alone or in combination with other aromatase inhibitors or therapeutic agents or as an adjuvant to conservative surgical treatment, such as laparoscopy, to prevent the establishment and/or continuation of the ectopic pregnancy. In certain preferred embodiments, the aromatase inhibitor is administered in conjunction with methotrexate.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully